Implementation of new ECMO centers during the COVID-19 pandemic

In this multicenter international cohort in 19 ECMO centres from five countries in the Middle East and India, 307 critically ill COVID-19 patients received ECMO therapy, of whom 138 (45%) survived to home discharge. The current study showed that new satellite ECMO centres could be safely implemented with appropriate close supervision of regional experts and may provide favourable outcomes in highly selected critically ill patients.Original study: Implementation of new ECMO centres during the COVID-19 pandemic: experience and results from the Middle East and India Speakers:Prof Alain COMBES. Professor of Intensive Care Medicine at Sorbonne Université, Paris (FR) and head of the ICU department at La Pitié-Salpêtrière Hospital, Assistance Publique Hopitaux de Paris (FR). Associate Editor of ICM.Dr Ahmed RABIE. Critical Care Acting ECMO Consultant - Head of CCD-ECMO committee at King Saud Medical City, Critical Care Department, Riyadh (SA).